chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a Pfizer-sponsored program. This is a spontaneous report from a contactable consumer (patient's mother) reporting for her daughter, and from a contactable physician. A 18-year-old female patient received the first dose of TRUMENBA, (Lot M68769), intramuscular in deltoid at 0.5 ml, single on 28Jun2016 for immunisation along with another meningococcal vaccine at the same time so she (reporter) did not know it was Pfizer's or the other one, and first dose of meningococcal vaccine (MENACTRA, Lot 05260AA), intramuscular in left deltoid. The patient medical history and concomitant medications were not reported. The patient experienced felt very sick on an unspecified date with outcome of recovered, chills on an unspecified date with outcome of unknown, fever on 29Jun2016 with outcome of recovered on 30Jun2016, couldn't go to work on an unspecified date with outcome of unknown, achy on an unspecified date with outcome of unknown and flu like symptoms on an unspecified date with outcome of recovered.  Therapeutic measures were taken as a result of fever and achy included Ibuprofen (200 mg, Pill, Orally). Follow-up (16Sep2016): New information received from a contactable physician includes vaccine details (Lot number, route and site of administration), new non serious event (flu like symptoms), outcome of some events.
Muscles in my left arm where given shot began to have severe pain. Lost strength in my arm also. It seemed to affect my shoulder down to my hand with pain which I began taking ADVIL for. Lots of trouble sleeping, for the many times I had to move my arm to relieve the pain briefly using my right hand to help hold up. As time went pain was under my arm, side of chest also sore putting pressure on shoulder. This is now October 19th and seems like most pain now is where I consider the rotator cup.   Still difficult to sleep even after taking Advil. The arm has gotten better, for now can raise my left arm without pain or help from my right hand. I have not had a fever, but am rather tired at times. I am treating myself, but never thought this problem would last this long. Did NOT go to my doctor, hospital, or have any tests.
Reaction affected his breathing, could not breathe,get short of breath even if he was sitting down,when he took a couple steps it was hard to breathe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Reaction affected his breathing, could not breathe,get short of breath even if he was sitting down,when he took a couple steps it was hard to breathe) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Reaction affected his breathing, could not breathe,get short of breath even if he was sitting down,when he took a couple steps it was hard to breathe). At the time of the report, DYSPNOEA (Reaction affected his breathing, could not breathe,get short of breath even if he was sitting down,when he took a couple steps it was hard to breathe) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications was reported. Treatment information was not provided.  The reaction he had happened shortly after the second shot. The reaction affected his breathing, he could not breathe and as a result of that he had a pacemaker put in July2021. He would get short of breath even if he was sitting down, when he took a couple steps it was hard to breathe. He stated he did not have COVID, he does not know, if he had it, it was after the second shot.
pt recv vax & broke out in red blotches on face & scalp was given DPH;
Information and follow up has been received from a nurse concerning a 68 year old male who on 22-APR-2008 was vaccinated intramuscularly in the left deltoid with pneumococcal 23v polysaccharide vaccine (lot# 658074/0803U). Concomitant therapy included fenofibrate (TRICOR). On 22-APR-2008, 12 hours after the vaccination, the patient experienced a fever, headache and reported feeling bad. The fever reached 102.2 F and "he didn't sleep all night." He reported a sore injection arm and general aches and pains. He saw the physician in the office on 23-APR-2008. At the office he had a fever of 101F while taking an unspecified fever medication. The physician prescribed an unspecified pain medication on 23-APR-2008 and felt the symptoms would resolve. The patient recovered. Additional information has been requested.
Redness and discomfort to inject site 7 cm x 9 cm area of redness on exam, occurred approximately 24 hrs. after receiving injection. First time receiving high dose vaccine.
Swelling at sight of injection approximately 1 cm diameter hardened center applied ice pack with relief.  Patient advised if signs & symptoms worsen to seek medical attention.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2013, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Received second dose of Moderna vaccine on 1/25/21. The next day she developed redness, warmth, and swelling to vaccinated extremity. Seen by facility, and PCP. Symptoms lasted 1 week.
This spontaneous report as received from a health care worker refers to a 12 month old patient. On 11-APR-2014 the patient was vaccinated with M-M-R II and PROQUAD (Merck) instead of M-M-R II and VARIVAX (Merck). No adverse effects reported. No product complaint was discovered. No product confusion just medication error was reported. The outcome was unknown. Additional information has been requested.
Fell off a kitchen island then started seizing. Hard to know when seizure happened after or proceeding the fall. Went to ER and was transported by ambulance to hospital. Doctor unsure if post vaccination caused seizure.
Zostavax vaccine given subcutaneous left upper arm 7-9-09.  Developed erythema, tenderness, swelling, and warmth at injection site on 7-10-09.  Saw physician 7-11-09, recommended ice, antihistamine, and prescribed CEFUROXIME 500 mg BID x 7 days.
Strange rash which resembled a puzzle shape or a geometric pattern on the same arm of the vaccine - for a few hours (then subsided)   No treatment.
Right eye and cheek is swollen; Right eye and cheek is swollen; right sided headache; right sided neck muscle spasm and tightness.; right sided neck muscle spasm and tightness.; This is a spontaneous report from a contactable Other HCP. This Other HCP (patient) reported that the 33-year-old female patient who received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), via Intramuscular on Arm right on 30Dec2020 at single dose for covid-19 immunisation. No Pregnant at the time of vaccination. Medical history included Asthma and Behcets syndrome. No Known allergies to medications, food, or other products. Concomitant medications included the patient received within 2 weeks of vaccination: Albuterol inhaler (Inhalation vapour, solution), Magnesium, ergocalciferol (VIT D), Ashwagandha. Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced right eye and cheek is swollen, right sided headache and right sided neck, muscle spasm and tightness from 07Jan2021 07:00AM. No COVID prior vaccination. No COVID tested post vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Treatment was received for the adverse event included OTC ADVIL, PPI, Sudafed. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered.   Information on the lot/batch number has been requested.
Pt recvd vax 3PM 3JAN94 & woke up AM 4JAN94 w/rash on shoulder lt above across back to other shoulder;
Information has been received from a RN concerning a 65 year old white female pt with no relevant medical history who on 09/17/03 at 16:30 was vaccinated IM in the left deltoid with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 645246/0029N). There was no illness at the time of vaccination. On 09/17/03, at 17:30, "several hours later", the pt developed swelling with an increased "circumference >1", redness, and pain at the injection site, described as it hurt to wear clothing and the pain extended from her shoulder to elbow. There were no relevant diagnostic studies performed. The pt took ibuprofen (therapy unspecified)(previously reported as no treatment was required). There was "no MD eval.". "The symptoms lasted for 2 days before the beginning to resolve, the duration was 7 days and the pt recovered on 09/23/03. There was no product quality complaint involved. No other information was provided. No further information is expected.
Itchy and sore too on day of shot and next day even more sore (or painful) and swollen.
- 3 hours after vaccination: Tensing occurred around the injection site. Pain can be described as fatigue, making it painful to move the muscles around the area of injection. The symptom lasted for two days. - 0215 the next day (1/26/2021): Headache occurred and lasted for approximately 36 hours.
Fever 100.5 night of vaccine and following morning. Sore muscles. Skin tender. Sore injection site.
redness is 2 inches wide and 4 inches long; soreness in the arm, redness is 2 inches wide and 4 inches long; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness is 2 inches wide and 4 inches long) and VACCINATION SITE PAIN (soreness in the arm, redness is 2 inches wide and 4 inches long) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness in the arm, redness is 2 inches wide and 4 inches long). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness is 2 inches wide and 4 inches long). At the time of the report, VACCINATION SITE ERYTHEMA (redness is 2 inches wide and 4 inches long) and VACCINATION SITE PAIN (soreness in the arm, redness is 2 inches wide and 4 inches long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the eventS, a causal relationship cannot be excluded
Patient received a flu shot instead of a COVID booster (Pfizer). Patient was planning on receiving the flu shot at a future date.
Tested positive for Covid-19; feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19) and FEELING ABNORMAL (feeling bad) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FEELING ABNORMAL (feeling bad). On 18-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for Covid-19) and FEELING ABNORMAL (feeling bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported
Cramps in both legs for two days after receiving booster. One week later, blood clots in right leg migrating to both lungs. PE in both lungs.
9 days after vaccination-temp of 102 and multiple chickenpox lesions on face and trunk-multiple lesions
After roughly 4 hours I started to get chills and body aches. I went to bed but could not get warm and writhed in considerable distress for at least an hour. (This was the most uncomfortable I've been since induced labor before the anesthesiologist arrived for an Epidural 28+ years ago.) My temperature fell to 95 before I took acetaminophen and was able to fall asleep.. Now, at 7 hours it's 101.2 and I'm just getting the side effects I expected: weakness, a little nausea.
This spontaneous report has been received from a licensed practical nurse referring to a 15 year old patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. In April 2018, the patient was vaccinated with improperly stored vaccines of GARDASIL 9 lot # N025428 with expiration date of 19-JUN-2020 (strength, dose, route, and anatomical location were not provided), RECOMBIVAX HB, VARIVAX and M-M-R II (strength, dose, route, anatomical location and lot/batch# were not provided) for prophylaxis. The vaccines were exposed to a temperature excursion below 32 degree Fahrenheit (31.1 degree F) for 8 hours and 27 minutes, also between 32 degree F to 35 degree F (32.5 degree F) for 4 hours and 33 minutes, which were called by a data logger. No adverse events were reported. Product quality control issue was not involved. This is one of the 46 reports from the reporter.
Since her last scan she started to complain about neuropathy pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 82-year-old female patient received BNT162b2 (BNT162B2), on 19Sep2021 as dose 3 (booster), single (Lot number: 7485) at the age of 81 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Lung Cancer" (unspecified if ongoing); "Thyroid" (unspecified if ongoing), notes: Levothyroxine for her thyroid. Levothyroxine 112 mg; "Allergies" (unspecified if ongoing); "Compromised immune status" (unspecified if ongoing); "Respiratory illness" (unspecified if ongoing); "Genetic/chromosomal abnormalities" (unspecified if ongoing); "Endocrine abnormalities (including diabetes)" (unspecified if ongoing); "Obesity" (unspecified if ongoing). Concomitant medication(s) included: TAGRISSO taken for neoplasm malignant; LEVOTHYROXINE taken for thyroid therapy. Vaccination history included: BNT162b2 (First vaccine, Lot: EL9267, Time given: 9:15 Morning, She said whatever was required and they put a needle in her.  Anatomical Location: Left arm and she said she was driving.), administration date: 19Feb2021, when the patient was 80-year-old, for COVID-19 immunization; BNT162b2 (Second vaccine, Lot: EN6207, Time given: 9:15 morning, Anatomical Location: Right arm and she was not driving), administration date: 12Mar2021, when the patient was 80-year-old, for COVID-19 immunization. The following information was reported: NEUROPATHY PERIPHERAL (medically significant), outcome "unknown", described as "Since her last scan she started to complain about neuropathy pain". The patient underwent the following laboratory tests and procedures: Blood test: (unspecified date) Unknown results, notes: They did special blood work and there will be no results for 6 to 7 days; Scan: (28Jun2022) 3 month scans the new spots showed up. Therapeutic measures were taken as a result of neuropathy peripheral.  Clinical information: The patient also received Covid-19 fourth vaccine (Lot: FP4554) on 13Apr2022 in the afternoon for COVID -19 immunisation. The patient cannot remember if the right or left arm because she was driving, she received at arm. The patient did not administer any additional Vaccines on Same Date of the Pfizer Suspect. The patient did not receive any prior vaccinations within 4 weeks to the first administration date of the suspect vaccine. The patient don't go to the doctor except of scans every 3 months and if she goes to doctor is for something silly like an ingrown toe nail and goes to podiatrist. The patient had other relatives that had cancer but not lung. She said she is a cancer patient and she said lung cancer for 8 years next month.  She has been stable and only taking Tagrisso.  Follow-up attempts are completed. No further information is expected.
After I got my second shot I had been diagnosed with prostate cancer. They told me I might experience some swelling in my lymph nodes that should go away after a few days. I experienced the swelling in my lymph nodes, but it took some time to go away. I noticed some swelling in my feet, ankles, calves, and in one of my knees that I had surgery on. It was unusual for me to get swelling like that. I experienced swelling in my calves sometimes but never to that degree. I occasionally experienced breathing that felt like fluid in my lungs at night when I try to lay down and sleep. I couldn't get a good sleep because of the feeling of fluid build up in my lungs. It would also be difficult to walk and I would get winded quickly. My doctor gave me a mild diuretic that helped some, but then when I ran out of that the symptoms came back. Sometimes I feel a sensation or something in my right lung.
Patient checked in for her vaccination appointment on Sunday 04/25/21 at approximately 03:50 pm. After speaking with the pharmacist she confirmed that she did not have any prior history of any allergies to any medications. She mentioned that she had a history of anxiety and was nervous about receiving the vaccination. She received her first dose of the Moderna Covid19 vaccine at between approximately 03:55 - 04:05 pm. She then went to the designated observation area. Before completing her observation period, the patient got up and walked to the pharmacy at which point she fainted and was lying on the floor in a supine position. The pharmacy staff was alerted and checked on the patient. The manager in charge was notified and came to the pharmacy. The patient was checked on for responsiveness and she was alert and responsive. She asked for her father who was in the store at the time and she also asked for some water. She stood up with some assistance and sat down in an observation chair. Her father came over and the technician provided the patient some water. The patient stayed an additional 15 minutes in her chair speaking to her father and drinking her water.  After which, she got up and left with her father.
Patient stated that 2-3 days after she got her first Pfizer vaccine, that was administered in the same arm that she has an implant in, she developed a small bump on her neck right around her collar bone.  She said that it was not painful and that it was kind of soft.  Patient stated that she will contact her doctor if the nodule gets worse.
Patient almost immediately began to itch in the injection site (R deltoid). Within minutes, a rash had developed on the patients arm and it had spread to her abdomen and left arm.  The injection site "knotted" up and became very red. Treatment: patient was told to take Benadryl and was given a steroid shot in the doctor's office.
Shortly after receiving the FluMist I got a headache and bad sore throat.  Later that night I became light headness and notice some wheezing when I took a deep breath.   The next day headache and sore throat continue but started with muscle aches all over.   Heart rate went up 40 beats from my baseline and felt like I was crawling out of my skin.  Never had a fever.   Second day felt better, just like I  had a bad cold, sore throat, head ache, runny nose and cough, tired.     4 days later still with bad cold symptoms.
Mild ache in thighs and joints after second shot , similar to aches after performing new exercise at gym.  No treatment.  After 48 hrs, symptoms are gone.